Navigation Links
Research Compares MENOPUR(R) With rFSH in GnRH Antagonist IVF Cycles
Date:10/20/2009

verse reactions, should prescribe MENOPUR®. MENOPUR®, like all gonadotropins, is a potent substance capable of causing mild to severe adverse reactions, including OHSS (overall incidence 3.8%), with or without pulmonary or vascular complications, in women undergoing therapy for infertility. MENOPUR® is contraindicated in women who have a high FSH level indicating primary ovarian failure; uncontrolled thyroid and adrenal dysfunction; an organic intracranial lesion such as a pituitary tumor; sex hormone dependent tumors of the reproductive tract and accessory organs; abnormal uterine bleeding of undetermined origin; ovarian cysts or enlargement not due to polycystic ovary syndrome; prior hypersensitivity to menotropins or MENOPUR®. MENOPUR® is not indicated in women who are pregnant. There are limited human data on the effects of menotropins when administered during pregnancy.

About ENDOMETRIN

ENDOMETRIN® administered as a progesterone vaginal insert is indicated to support embryo implantation and early pregnancy by supplementation of corpus luteal function as part of an Assisted Reproductive Technology (ART) treatment for infertile women.

Important Safety Information

Only physicians thoroughly familiar with infertility treatment should prescribe ENDOMETRIN®. In clinical trials (n=808), adverse reactions that occurred at a rate greater than or equal to 2 percent included: uterine spasm (3% to 4%) and vaginal bleeding (3%). Vaginal irritation, itching, burning or discomfort, urticaria, and peripheral edema were reported at an incidence of less than 2 percent. ENDOMETRIN® is expected to have adverse reactions similar to other drugs containing progesterone (breast tenderness, bloating, mood swings, irritability, and drowsiness). ENDOMETRIN® is contraindicated in women who have or have had previous allergic reactions to progesterone or any of the ingredients in E
'/>"/>

SOURCE Ferring Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. comScore Study Finds the Internet a Key Component in Consumer Research on Prescriptions and Health Conditions
2. $500 Billion Health Care Spend Boosts BRIC Countries Diagnostic Imaging Sales Despite Global Recession, According to Millennium Research Group
3. New Effort to Battle Antibiotic Resistance Rallies Researchers Throughout Harvard University
4. National Institutes of Health Awards More Than $54 Million to Kaiser Permanente to Conduct Health Research
5. Outcomes Registry in Heart Attack Patients to Generate Numerous Studies; Data Quality Ensured Through Velos Clinical Research Management System
6. Two Hutchinson Center Scientists Receive a Total of $16.7 Million for Collaborative Stem Cell Research
7. Cornerstone Pharmaceuticals Adds Acclaimed Cancer Research Pioneer Robert A. Weinberg, Ph.D. to Its Scientific Advisory Board
8. Dynatronics Appoints Douglas Sampson as Vice President of Production and Research & Development
9. Peregrine Pharmaceuticals Forms Anti-Viral Research Group to Oversee Its Anti-PS Infectious Disease Collaborations
10. The Japanese Cancer Association and Debiopharm Group Present the JCA-Mauvernay Award to Dr Ushijima for his Oncology Research
11. Sigma-Aldrich(R) Receives Award From Michael J. Fox Foundation to Develop Parkinsons Disease Research Models
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... December 16 , ... With Microplasmin Recruits a Total of Over,640 ... ThromboGenics NV (Euronext Brussels: THR), ... development of innovative treatments for eye,disease, vascular ... has completed,the enrolment of the second Phase ...
(Date:12/15/2009)... Dec. 15 Immucor, Inc. (Nasdaq: BLUD ... to the blood transfusion industry, today announced that it ... Wednesday, January 6, 2010 after the market close. The ... 7, 2010 at 8:30 a.m. (Eastern Time) to discuss ... participate in this conference call by dialing 1-888-324-9321 (Passcode: ...
(Date:12/15/2009)... Robbins & Myers, Inc. (NYSE: ... for its fiscal 2010 first quarter ending November 30, ... 2010. A live webcast is scheduled for ... Peter C. Wallace, President and Chief Executive ... Financial Officer, will be discussing the Company,s performance and ...
Breaking Medicine Technology:ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 2ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 3ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 4New Health Reform Campaign Will Support Long Term Care for All Because 3 in 4 Need More 54155 1New Health Reform Campaign Will Support Long Term Care for All Because 3 in 4 Need More 54155 2New Health Reform Campaign Will Support Long Term Care for All Because 3 in 4 Need More 54155 3Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 1Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 2Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 3Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 4Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 5Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 6Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 7Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 8Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 9Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 10Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 11Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 12Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 13Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results 54150 14Detroit Physician Herbert C Smitherman Jr M D Awarded 2425 000 in J H Kanter Prize Competition 54147 1
... SAN MATEO, Calif., April 16 Anthera ... drugs, announced today that after completing its ... an independent Data Safety,Monitoring Board (DSMB) has ... as the IMPACTS (Investigation of the Modulation ...
... on whether the federal government is doing enough to ... culprit is the,CDC. The CDC claims 1.7 million people ... several times that number. The proof is,in the data., ... or MRSA, which stands,for methicillin-resistant Staphylococcus aureus, a superbug ...
Other Medicine Technology:DSMB Supports Continuation of Anthera Phase II Impacts Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease 2April 16th Congressional Hearing on Hospital Infections 2
(Date:12/16/2009)... free 21-count one week trial bottle sample with purchase of 90-count ... ... 2009 -- ImmuneResponse247.com announces a special free offer ... Response 247™ 6 Mushroom Formula , with the purchase of a ... Mushroom Formula is packaged in FDA approved facilities and blends the ...
(Date:12/16/2009)... is proud to announce being presented with the Weatherhead 100 Upstart ... fastest growing companies in Northeast Ohio and is a testament to ... , ... (PRWEB) December 16, 2009 -- Request ... Weatherhead 100 Upstart Award on December 3, 2009. The Weatherhead ...
(Date:12/16/2009)... perfect gift to give that special woman who has everything? ... Mary Schook introduces exceptional beauty products online while educating the public ... ... (PRWEB) December 16, 2009 -- The holidays are rapidly approaching ... woman who has everything? Why stem cells, of course!, , , ...
(Date:12/15/2009)... SUMMARY: The U.S. Senate today rejected an ... Act that would have helped make prescription drugs ... legal importation of lower priced drugs from abroad. ... by Senators Dorgan, Snowe, McCain, Grassley and Stabenow, ... down the skyrocketing costs of prescription drugs. ,, ...
(Date:12/15/2009)... in the healthcare bill ,, WASHINGTON, Dec. 15 ... the "Naughty" column on Americans for Tax Reform,s 2009 ... brazen lie on the floor of the United States Senate: ... ,, Speaking on the U.S. Senate floor on Nov. ... I have also heard it argued that health care reform ...
Breaking Medicine News(10 mins):Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 2Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 3Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 4Health News:Request A Test Receives Weatherhead 100 Upstart Award 2Health News:New Online Beauty Store Suggests Stem Cells for the Woman Who Has Everything 2Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 2Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 3Health News:ATR: Baucus Earns Place on 2009 "Naughty" List 2Health News:ATR: Baucus Earns Place on 2009 "Naughty" List 3
... access for patients to needed cancer diagnosis tool ... a global leader in healthcare technology, supports the ... for Medicare and Medicaid Services (CMS), expanding coverage ... for Medicare beneficiaries who are diagnosed with and ...
... PHILADELPHIA, April 7 Hahnemann University Hospital is pleased ... B. Burke, FACHE , has been appointed to the ... (PTSF). Recommended by the Hospital & Healthsystem Association of ... was approved by the PTSF at their board meeting ...
... Industry Generates 130,000 Jobs and $13.5 Billion in Economic ... an essential and vital part of the state,s economy, ... according to a report released today ... economic profile prepared by the Taylor Feldman Group, an ...
... ASTHMA EPISODES DECREASE WITH REDUCED ETS EXPOSURE , ... poor asthma outcomes in children. However, a new ... improve asthma outcomes. University of Alabama researchers followed ... usual care or supervised asthma therapy. No smoking ...
... Experts Featured In Film SAN FRANCISCO, April 7 , WHAT: ... Alzheimer,s Disease Center, UCSF Memory & Aging Center ... Alzheimer,s Association, No. Cal. present an advance, ... HBO,s THE ALZHEIMER,S PROJECT free ...
... CareRise, a risk management company based in Mandeville, Louisiana, ... specialty hospitals, was recently approved by the U.S. Department ... Organization (PSO). CareRise,s listing became effective April 1 ... website for the Agency for Healthcare Research and Quality ...
Other Medicine News:Health News:GE Healthcare Applauds CMS for Supporting National FDG-PET Coverage Decision 2Health News:Hahnemann COO Elected to the Pennsylvania Trauma System Foundation Board 2Health News:California Health Plans Vital to State's Economy 2Health News:Journal Chest: April news briefs 2Health News:HBO, Gladstone Institute of Neurological Disease, UC Davis Alzheimer's Disease Center, UCSF Memory & Aging Center and The Alzheimer's Association, No. Cal. Present an Advance Screening of THE ALZHEIMER'S PROJECT: 'Momentum In Science' 2Health News:U.S. Department of Health and Human Services Names CareRise a Patient Safety Organization 2
... Durable ergonomic chairs with concave ... support • Select options like seats, ... • Choose the BE Series for ... environments including: industry, education, laboratory, clean ...
... with concave seats and large backrests with ... backrests, armrests, and casters and glides. • ... in a variety of environments including: industry, ... care and office. • With reinforced nylon ...
... seats and large backrests with lumbar support ... and casters and glides. • Choose the ... variety of environments including: industry, education, laboratory, ... office. • With reinforced nylon base • ...
... Durable ergonomic chairs with concave seats and ... options like seats, backrests, armrests, and casters ... for top performance in a variety of ... static control, health care and office. • ...
Medicine Products: